VAL — ValiRx Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for ValiRx, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.594	1.14	0.175	1.56	0.792
Net Total Accounts Receivable
Net Total Receivables	0.167	0.265	0.244	0.238	0.184
Total Inventory
Prepaid Expenses
Total Current Assets	0.8	1.46	0.566	1.9	1.09
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.013	0.006	0.243	0.202	0.13
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	3.52	3.98	3.13	4.26	2.63
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.068	0.128	0.215	0.345	0.235
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	-0.075	-0.075	-0.088	-0.055	-0.223
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.6	4.05	3.22	4.32	2.86
Total Liabilities & Shareholders' Equity	3.52	3.98	3.13	4.26	2.63
Total Common Shares Outstanding